| Trial ID: | L0331 |
| Source ID: | NCT00162487
|
| Associated Drug: |
Albuterol (1,200 Μg) Through Metered-Dose Inhaler
|
| Title: |
Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hyperkalemia|Chronic Renal Failure
|
| Interventions: |
DRUG: Albuterol (1,200 μg) through metered-dose inhaler
|
| Outcome Measures: |
Primary: The extent of decrease in plasma potassium concentration|The extent of increase in plasma glucose concentration|Plasma concentration of albuterol |
|
| Sponsor/Collaborators: |
Sponsor: Hadassah Medical Organization
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
150
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-08
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2008-10-29
|
| Locations: |
Hadassah Medical Organization, Jerusalem, 91120, Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT00162487
|
